Loading...

By MBN Staff - Wed, 07/31/2024 - 17:22

Leqembi's data shows a 31% reduction in cognitive decline, with no new safety issues, contrasting with Lilly’s Kisunla in cost and approach.

Partnership Content

https://mexicobusiness.news/tag/kisunla

More Health

By MBN Staff - Thu, 07/04/2024 - 09:59

The FDA approves Eli Lilly's Alzheimer's drug Kisunla, marking a significant advance in treatment options for early-stage Alzheimer's patients.